TinyGemsBreaks Archive - Page 11 of 136

WednesdayJul 16, 2025 9:40 am

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Initiates CUSIP Change to Bolster Shareholder Protections Amid Rebrand

SEGG Media (NASDAQ: SEGG, LTRYW), formerly Lottery.com, announced a CUSIP number change as part of its corporate rebrand and ongoing efforts to combat illicit trading activity. The move aims to enhance market transparency and counter suspected naked short selling that has impacted trading. Now trading under the SEGG ticker, the company is working with counsel at Paul Hastings LLP to pursue regulatory action while advancing its global expansion in sports, entertainment, and gaming. To view the full press release, visit https://ibn.fm/ted9T About SEGG Media Corporation SEGG Media (Nasdaq: SEGG, LTRYW) is a global sports, entertainment and gaming group operating digital…

WednesdayJul 16, 2025 9:00 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights August as Key Window for Commercial EV Incentives Through Bollinger Motors

Mullen Automotive (NASDAQ: MULN), through its subsidiary Bollinger Motors, announced that August will present a prime opportunity to purchase commercial EVs as New York’s Truck Voucher Incentive Program (NYTVIP) is set to be replenished. The program offers up to $144,000 in point-of-sale vouchers, which, when combined with the federal 45W tax credit of up to $40,000 for Class 4 vehicles, delivers major upfront savings. With federal credits expiring after September 30, 2025, Bollinger urges fleet operators to act swiftly. The Bollinger B4, an all-electric Class 4 chassis cab, qualifies for these programs and is engineered for performance, safety, and urban…

MondayJul 14, 2025 1:27 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Boosts Brand Visibility at Iowa INDYCAR Weekend Ahead of Toronto Showcase

SEGG Media (NASDAQ: SEGG, LTRYW), a tech leader at the crossroads of sports, entertainment, and gaming, reported strong brand momentum following an impactful weekend at Iowa Speedway. Flagship platforms Sports.com and Lottery.com gained visibility through high-profile INDYCAR exposure, including on-car branding and broadcast coverage. Rookie Louis Foster maintained his lead in the Rookie of the Year standings, delivering consistent performances, while Callum Ilott and Robert Shwartzman showcased speed and resilience. SEGG Media now turns to the Toronto street circuit, leveraging the growing media presence and fan engagement to expand its motorsport marketing footprint across North America. To view the full…

FridayJul 11, 2025 12:41 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Backs High-Speed Action at INDYCAR Iowa Speedway Doubleheader

SEGG Media (NASDAQ: SEGG, LTRYW) announced that its Lottery.com and Sports.com-sponsored drivers will compete in this weekend’s NTT INDYCAR Series and INDY NXT by Firestone doubleheader at Iowa Speedway. The 0.875-mile oval, dubbed the “Fastest Short Track on the Planet,” will test teams with its demanding layout. PREMA Racing’s Callum Ilott and Robert Shwartzman aim to capitalize on recent progress following June testing at the track. Andretti Global, riding momentum from its 300th win at Mid-Ohio, brings strong credentials to Iowa with a history of 10 wins and 26 podiums at the venue. In INDY NXT, Seb Murray prepares for…

FridayJul 11, 2025 9:00 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in NetworkNewsWire Spotlight on Genetic Medicines

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech innovator, announced its inclusion in an editorial by NetworkNewsWire titled “Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers.” The article highlights Calidi’s next-generation platform, which uses engineered viruses to deliver genetic therapies directly to primary and metastatic tumors. While oncology is the company's initial focus, it is also evaluating applications in autoimmune disorders, underscoring its broader therapeutic potential. The editorial emphasizes Calidi’s role in addressing the rising global cancer burden and advancing transformative treatment options. To view the full press release, visit: https://ibn.fm/18sdm About Calidi Biotherapeutics Calidi Biotherapeutics is a clinical-stage immuno-oncology…

ThursdayJul 10, 2025 2:44 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Signs LOI to Launch David Lloyd-Branded U.S. Sports Arena

SEGG Media (NASDAQ: SEGG, LTRYW), a global technology company at the intersection of sports, entertainment and gaming, has signed a binding Letter of Intent with legendary sports entrepreneur David Lloyd to acquire the rights to his All-Sports Arena in Boca Raton, Florida, at a $14 million valuation. Signed during Wimbledon at the Members’ Enclosure, the agreement marks the U.S. debut of the David Lloyd brand. The 100,000-square-foot facility will be branded “Sports.com All-Sports Arena, designed by David Lloyd,” blending premium athletic infrastructure, co-working space, and hospitality elements. It will feature AI-powered golf simulators, indoor courts, a full-service gym, and a…

ThursdayJul 10, 2025 11:37 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Raises $4.6 Million Through Warrant Exercise Agreement

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotech firm developing targeted therapies for genetic medicine delivery, announced a definitive agreement for the immediate cash exercise of outstanding warrants totaling 6,595,000 shares of common stock at a reduced price of $0.70 per share. The transaction is expected to generate approximately $4.6 million in gross proceeds. In exchange, the company will issue new unregistered warrants with the same share count, exercisable in six months at $0.70 and valid for five and a half years. Ladenburg Thalmann & Co. Inc. is serving as exclusive placement agent. Calidi plans to use the net proceeds…

WednesdayJul 09, 2025 11:31 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Lead Program in Virtual CEO Segment

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company focused on treating primary and metastatic cancers in the brain and central nervous system, announced CEO John Climaco’s participation in a Virtual Investor CEO Connect segment. Climaco provided an overview of the Company’s lead candidate, TPI 287, and shared insights from the Longwood Healthcare Leaders Spring 2025 Meeting in Cambridge, Massachusetts. To view the full press release, visit https://ibn.fm/cRmQS About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The…

TuesdayJul 08, 2025 2:35 pm

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Emerges from Lottery.com Rebrand with Global Sports, Entertainment and Gaming Vision

SEGG Media (NASDAQ: SEGG, LTRYW), formerly Lottery.com Inc., has completed its corporate rebrand and strategic overhaul, signaling a new era as a global sports, entertainment, and ethical gaming conglomerate. Trading under the new SEGG ticker, the company now operates across three verticals: Sports.com (live streaming, sim racing, eSports), Entertainment (event streaming, music, fashion), and Lottery.com (iGaming and charity-aligned gaming). Following a $300 million equity line, SEGG Media is focused on non-dilutive growth, asset-backed acquisitions, and fan-first digital experiences, with major initiatives expected in global motorsports, storytelling content, and branded facilities. To view the full press release, visit https://ibn.fm/4RHJC About SEGG…

TuesdayJul 08, 2025 12:18 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Featured in Editorial Highlighting Breakthrough Genetic Medicine Platform

Calidi Biotherapeutics (NYSE American: CLDI) announced its feature in a NetworkNewsWire editorial discussing the company’s precision genetic medicine platform, which targets both primary and metastatic cancer tumors using engineered viruses. With global cancer diagnoses expected to reach 35 million annually by 2050, Calidi’s approach represents a potential breakthrough in addressing critical unmet needs. The company’s platform aims to deliver potent genetic therapies directly to cancer sites, offering a novel and potentially disruptive solution in the fight against cancer. To view the full press release, visit: https://ibn.fm/wj9TN About Calidi Biotherapeutics Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology designed…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks